1576
F. Maccari et al. / Carbohydrate Research 345 (2010) 1575–1580
as a SYSADOA (Symptomatic Slow Acting Drug for OA) drug in Eur-
ope in the treatment of knee osteoarthritis (OA) based on meta-
analysis of numerous clinical studies.7 Moreover, CS alone or in
combination with glucosamine is utilized as a dietary supplement
based on meta-analysis of studies confirming its safe and effective
options for the treatment of symptoms of OA.8
CS, like other natural polysaccharides, is derived from animal
sources by extraction and purification processes.1 Commercial
manufacture of CS relies at present on bovine,9 porcine,9 chicken,10
or cartilaginous fish such as sharks11 and skate12,13 by-products, in
particular, cartilage as raw material.
D
UA-2s-[1?3]-GalNAc-4s),
GalNAc-6s), di4,6dis ( Di-dis E,
Di2,4,6tris ( Di-tris, UA-2s-[1?3]-GalNAc-4s,6s)] were from
D
Di2,6dis (
DDi-dis D, DUA-2s-[1?3]-
D
D
D
D
D
UA-[1?3]-GalNAc-4,6dis), and
D
Seikagaku Corporation (Tokyo City, Japan). Stains-All (3,30-di-
methyl-9-methyl-4,5,40,50-dibenzothiacarbocyanine) was from Sig-
ma. QAE SephadexÒ A-25 anion-exchange resin was from Pharmacia
Biotech (Uppsala, Sweden). Spectrapore dialysis tubing (Mr 1000
daltons cut off) was from Spectrum (Rancho Dominguez, CA, USA).
All other reagents were of analytical grade.
2.2. Purification of sturgeon CS
As previously illustrated, due to its very complex heterogeneous
structure, CS from different sources may possess repeating disac-
charides having various sulfate groups located, in different per-
centages, inside the polysaccharide chains (see Fig. 1). These
repeating disaccharide units are generally monosulfated but,
depending on the origin, various disulfated disaccharides (and pos-
sibly also a trisulfated one) may be present in the polysaccharide
backbone. As a consequence, CS with different charge densities
may be produced from various sources. Furthermore, as a result
of the biosynthetic processes related to specific tissues and species,
CSs with different grades of polymerization may be biosynthetized
producing macromolecules having various molecular masses and
polydispersity. Due to these structural variations, CS from different
sources may have different properties and capacities.
The above-mentioned considerations have motivated us to look
for alternative sources of this complex polysaccharide also consid-
ering the possibility of producing CS with a particular repeating
disaccharide composition, structure, and activity. In this regard,
the sturgeon belongs to one of the oldest families of bony fish in
existence. It is a native of subtropical, temperate, and sub-Arctic
rivers, lakes, and coastlines of Eurasia and North America but it
is also found along the European Atlantic coast, including the Med-
iterranean Sea.14 The common name is used for some 26 species of
fish in the Acipenseridae family, including over 20 species com-
monly referred to as sturgeon and several closely related species
that have distinct common names, notably sterlet, kaluga, and be-
luga. Collectively, the family is also known as the true sturgeons.14
Where sturgeons are caught in large quantities, as in the rivers of
southern Russia and in the great lakes of North America, their flesh
is dried, smoked, or salted. The ovaries, which are large in size, are
prepared for caviar, and the air bladder is used to produce one of
the best kinds of gelatine,15 while the rest of the animals is usually
discarded. In this study, CS was extracted and purified from stur-
geon bones and its structure characterized along with its impor-
tant physico-chemical properties, thus demonstrating that
another part of these animals might be exploited for commercial
preparations.
Sturgeon bones (ꢀ50 g) were defatted by grinding with 100 mL
of acetone, followed by filtration and drying at 60 °C for 24 h. The
pellet was solubilized (1 g/10 mL) in 100 mM Na–acetate buffer pH
5.5 containing 5 mM EDTA and 5 mM cysteine. 50 mg of papain
were added per g of tissue and the solution incubated for 24 h at
60 °C in a stirrer. After boiling for 10 min, the mixture was centri-
fuged at 5000g for 15 min, and three volumes of ethanol saturated
with sodium acetate were added to the supernatant and left at
+4 °C for 24 h. The precipitate was recovered by centrifugation at
5000g for 15 min and dried at 60 °C for 6 h. The dried precipitate
was dissolved in 50 mL of 50 mM NaCl. After centrifugation at
10,000g for 10 min, the supernatant was applied to a column
(2 cm ꢁ 40 cm) packed with QAE SephadexÒ A-25 anion-exchange
resin equilibrated with the same NaCl solution. GAGs were eluted
with a linear gradient of NaCl from 50 mM to 1.2 M in 150 min
using low-pressure liquid chromatography (Biological LP chroma-
tography system from BioRad) at a flow of 1 mL/min. Two volumes
of ethanol were added to the collected fractions corresponding to
fractionated species of polysaccharides evaluated by uronic acid
assay16 and agarose gel electrophoresis.17,18 After precipitation at
4 °C and centrifugation at 10,000g for 10 min, the pellet was dried
at 60 °C and solubilized in 20 mM Tris-Cl buffer pH 8.0 containing
2 mM MgCl2 and treated with DNAse I (750 mg) at 37 °C for 12 h.
After boiling for 5 min, NaCl concentration was brought to 16%
and the GAGs were precipitated by adding 80% methanol. The
recovered precipitate (ꢀ0.1 g) was solubilized in 20 mL doubly dis-
tilled water, dialyzed overnight at 4 °C, and freeze-dried for further
characterization.
2.3. Agarose gel electrophoresis
Agarose gel electrophoresis in barium acetate–1,2-diaminopro-
pane was performed as reported elsewhere17,18 with minor modi-
fications.
A Pharmacia Multiphor II (from Pharmacia LKB
Biotechnology, Uppsala, Sweden) electrophoretic cell instrument
was used. Agarose gel was prepared at a concentration of 0.5% in
0.04 M barium acetate buffer pH 5.8. The run was in 0.05 M 1,2-
diaminopropane (buffered at pH 9.0 with acetic acid) for 150 min
at 50 mA. After migration, the plate was soaked in cetyltrimethyl-
ammonium bromide 0.1% solution for at least 6 h, dried and
stained with toluidine blue.18 Extracted CS was also evaluated by
agarose gel electrophoresis after treatment with various lyases.
2. Experimental
2.1. Materials and methods
Heparin from bovine intestinal mucosa, heparan sulfate from bo-
vine kidney, CS from bovine trachea, DS from porcine intestinal mu-
cosa, and HA from rooster comb were from Sigma–Aldrich (St. Louis,
MO, USA). Papain from papaya latex (EC 3.4.22.2), specific activity of
16–40 units/mg protein, and deoxyribonuclease I, DNase I (EC
3.1.21.1) from bovine pancreas, specific activity of 10,000 units/
mL, were from Sigma–Aldrich. Chondroitinase ABC from Proteus
vulgaris (EC 4.2.2.4), specific activity of 0.5–2 units/mg, and
chondroitinase B from Flavobacterium heparinum (EC 4.2.2.), specific
activity of 100–300 units/mg, were from Sigma–Aldrich. Unsatu-
2.4. Enzymatic treatments and disaccharide evaluation
After treatment of purified CS with chondroitinase ABC or B, the
generated unsaturated disaccharides were separated and quanti-
fied by strong anion-exchange (SAX)-HPLC using an HPLC equip-
ment from Jasco equipped with a 150 ꢁ 4.6-mm stainless-steel
column spherisorb 5-SAX (5 lm, trimethylammoniopropyl groups
Si–CH2–CH2–CH2–N+(CH3)3 in Clꢂ form, from Phase Separations
Limited, Deeside Industrial Park, Deeside Clwyd, U.K.) and detec-
tion at 232 nm. Isocratic separation was performed using 50 mM
NaCl pH 4.00 for 5 min followed by a linear gradient from 5 to
rated chondro/dermato disaccharides
[
D
D
D
Di0s
Di6s (
Di2,4dis (D
(
D
UA-[1?3]-
UA-[1?3]-Gal-
Di-dis B,
GalNAc),
NAc-6s),
D
D
Di4s (
Di2s (
D
D
UA-[1?3]-GalNAc-4s),
UA-2s-[1?3]-GalNAc),
D